2,7-dichloro-4H-pyrido[1,2-a]pyrimidin-4-one | 278614-91-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶并嘧啶类
• 英文名称: 2,7-dichloro-4H-pyrido[1,2-a]pyrimidin-4-one
• 英文别名: 2,7-dichloropyrido[1,2-a]pyrimidin-4-one
• CAS: 278614-91-8
• 化学式: C₈H₄Cl₂N₂O
• mdl: MFCD07692319
• 分子量: 215.039
• InChiKey: NTUDDGZNPQEOQZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  32.7
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2,7-dichloro-4H-pyrido[1,2-a]pyrimidin-4-one 在 吡啶 、 溴 作用下， 以 二氯甲烷 为溶剂， 以64 %的产率得到3-bromo-2,7-dichloro-pyrido[1,2-a]pyrimidin-4-one
  参考文献：
  名称：

  [EN] PROTACS FOR TARGETED DEGRADATION OF KAT2A AND KAT2B FOR THE TREATMENT OF CANCER
  [FR] PROTAC POUR LA DÉGRADATION CIBLÉE DE KAT2A ET DE KAT2B POUR LE TRAITEMENT DU CANCER

  摘要：

  The present invention relates to bifunctional compounds (PROTACs) of formula (I) that target the degradation of KAT2A and KAT2B, their manufacture, pharmaceutical compositions comprising the compounds and the compounds for use as medicaments. The compounds of the invention are useful in the treatment of diseases and medical conditions associated with KAT2A and KAT2B, including, for example, cancer, autoimmune conditions, and inflammatory conditions.

  公开号：

  WO2024003533A1
• 作为产物：
  描述：

  ethyl 3-[(5-chloropyridin-2-yl)amino]-3-oxopropanoate 在 PPA 、 三氯氧磷 作用下， 反应 3.0h， 以61%的产率得到2,7-dichloro-4H-pyrido[1,2-a]pyrimidin-4-one
  参考文献：
  名称：

  Synthesis, antiplatelet activity and comparative molecular field analysis of substituted 2-amino-4 H -pyrido[1,2- a ]pyrimidin-4-ones, their congeners and isosteric analogues

  摘要：

  2-(1-Piperazinyl)-4H-pyrido[1,2-a]pyrimidin-4-one (5a) is a recently described in vitro inhibitor of human platelet aggregation which specifically inhibits the activity of high affinity cAMP phosphodiesterase. A number of substitution derivatives, isosteres, and analogues of 5a were now synthesized and tested in vitro for their inhibitory activity on human platelet aggregation induced in platelet-rich plasma by ADP, collagen, or the Ca2+ ionophore A23187. Among the most effective compounds, the 6-methyl, 8-methyl and 6,8-dimethyl derivatives of 5a resulted nearly as active as the lead when platelet aggregation was induced by ADP or A23187, but less active when collagen was the inducer. On the basis of present results and those previously obtained by us in this and 2-aminochromone structural fields, we have developed a statistically significant 3-D QSAR model, using comparative molecular field analysis (CoMFA), describing the variation of the antiplatelet activity in terms of molecular steric and electrostatic potential changes. (C) 2000 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(00)00010-9

文献信息

• WO2024069646A1
  申请人：——

  公开号：——

  公开（公告）日：——